Nephrocare Health Se
Ticker > Company >

Nephrocare Health Se share price

Nephrocare Health Services Ltd.

NSE: NEPHROPLUS BSE: 544647 SECTOR: Hospital & Healthcare Services  1.52 K   2   0

494.20
-1.45 (-0.29%)
BSE: 21 Jan 04:01 PM

Price Summary

Today's High

₹ 502.5

Today's Low

₹ 476.45

52 Week High

₹ 517.5

52 Week Low

₹ 445

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4958.84 Cr.

Enterprise Value

₹ 5048.44 Cr.

No. of Shares

10.03 Cr.

P/E

144.84

P/B

5.53

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  89.32

CASH

₹ 33.42 Cr.

DEBT

₹ 123.03 Cr.

Promoter Holding

63.85 %

EPS (TTM)

₹  3.41

Sales Growth

24.61%

ROE

7.44 %

ROCE

9.56%

Profit Growth

781.92 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year24.61%
3 YearNA
5 YearNA

Profit Growth

1 Year781.92%
3 YearNA
5 YearNA

ROE%

1 Year7.44%
3 Year1.47%

ROCE %

1 Year9.56%
3 Year4.27%

Debt/Equity

0.2324

Price to Cash Flow

62.2

Interest Cover Ratio

4.1722

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 63.85 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 55.396 Cr.
  • Company’s PEG ratio is 0.187152933349022.
  • The company has an efficient Cash Conversion Cycle of -1.11490000000001 days.
  • Company has a healthy liquidity position with current ratio of 2.1385.
  • The company has a high promoter holding of 63.85%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 21.1890177460458.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 1.47363333333333% over the past 3 years.
  • Company has a poor ROCE of 4.2748% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 45.6815.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 386.11 436.23 543.6
Total Expenditure 348.15 384.27 448.71
Operating Profit 37.97 51.96 94.88
Other Income 5.09 7.8 15.63
Interest 15.03 16.82 14.3
Depreciation 40.91 42.73 50.86
Exceptional Items 0 0 0
Profit Before Tax -12.88 0.22 45.36
Tax 2.59 -3.67 11.12
Net Profit -15.47 3.88 34.24
Adjusted EPS (Rs.) -17.78 4.44 38.79

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.14 5.14 5.43
Total Reserves 391.51 399.07 536.58
Borrowings 81.48 63.95 45.9
Other N/C liabilities -5.35 -9.37 -4.18
Current liabilities 156.85 185.03 154.9
Total Liabilities 629.63 643.83 738.63
Assets
Net Block 168.51 218.64 233.97
Capital WIP 0.44 0.69 4.3
Intangible WIP 2.19 0 0
Investments 147.93 148.57 161.6
Loans & Advances 9.32 15.75 6.32
Other N/C Assets 18.65 3.63 1.18
Current Assets 282.59 256.55 331.25
Total Assets 629.63 643.83 738.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Profit from operations -12.88 0.22 45.36
Adjustment 57.45 64 60.86
Changes in Assets & Liabilities -37.38 -1.66 -29.92
Tax Paid 3.95 -5.81 3.43
Operating Cash Flow 11.14 56.75 79.73
Investing Cash Flow -74.71 -22.67 -103.52
Financing Cash Flow 63.39 -35.54 26.02
Net Cash Flow -0.18 -1.46 2.23

Corporate Actions

Investors Details

PARTICULARS Dec 2025%
promoters 63.85
bessemer venture partners... 8.66
edoras investment holding... 28.30
healthcare parent limited... 5.80
investcorp india alternat... 0.47
investcorp private equity... 5.32
manvi family trust (trust... 1.77
pankaja gatuku 0.02
quadria capital india fun... 1.88
vikram vuppala 9.79
viraaj family trust (trus... 1.85
PARTICULARS Dec 2025%
investors 36.15
360 one special opportuni... 1.43
icici prudential retireme... 1.12
international finance cor... 3.08
investcorp india investme... 6.29
sbi healthcare opportunit... 1.17

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Nephrocare Health Se Stock Price Analysis and Quick Research Report. Is Nephrocare Health Se an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nephrocare Health Se. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nephrocare Health Se has a PE ratio of 146.805392731536 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nephrocare Health Se has ROA of 4.9529% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nephrocare Health Se has a Current ratio of 2.1385.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nephrocare Health Se has a ROE of 7.4408%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Nephrocare Health Se has a Debt to Equity ratio of 0.2324 which means that the company has low proportion of debt in its capital.

  • Sales growth: Nephrocare Health Se has reported revenue growth of 24.6125% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Nephrocare Health Se for the current financial year is 17.4546585062096%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nephrocare Health Se is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nephrocare Health Se is Rs 3.412. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nephrocare Health Se in Ticker for free. Also, one can get the intrinsic value of Nephrocare Health Se by using Valuation Calculators, which are available with a Finology ONE subscription. 

Nephrocare Health Se FAQs

Q1. What is Nephrocare Health Se share price today?
Ans: The current share price of Nephrocare Health Se is Rs 500.9.

Q2. What is the market capitalisation of Nephrocare Health Se?
Ans: Nephrocare Health Se has a market capitalisation of Rs 5026.06651453 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Nephrocare Health Se?
Ans: The PE ratio of Nephrocare Health Se is 146.805392731536 and the P/B ratio of Nephrocare Health Se is 5.60767542877614, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Nephrocare Health Se share?
Ans: The 52-week high share price of Nephrocare Health Se is Rs 517.85, and the 52-week low share price of Nephrocare Health Se is Rs 446.

Q5. Does Nephrocare Health Se pay dividends?
Ans: Currently, Nephrocare Health Se does not pay dividends. Dividend yield of Nephrocare Health Se is around 0%.

Q6. What are the face value and book value of Nephrocare Health Se shares?
Ans: The face value of Nephrocare Health Se shares is Rs 2, while the book value per share of Nephrocare Health Se is around Rs 89.324. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Nephrocare Health Se?
Ans: Nephrocare Health Se has a total debt of Rs 123.027 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Nephrocare Health Se?
Ans: The ROE of Nephrocare Health Se is 7.4408% and ROCE of Nephrocare Health Se is 9.5632%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Nephrocare Health Se a good buy for the long term?
Ans: The Nephrocare Health Se long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Nephrocare Health Se undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Nephrocare Health Se appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Nephrocare Health Se’s financials?
Ans: You can review Nephrocare Health Se’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Nephrocare Health Se Share Price News

Latest updates on Nephrocare Health Se share price and stock news.

View More Blogs
Last Updated on:
Brief about Nephrocare Health Se

Nephrocare Health Services Share Price, Business Overview & News

Nephrocare Health Services Limited, widely recognised by its brand NephroPlus, made its debut on the Indian stock exchanges today, December 17, 2025. As India's largest network of dialysis centers, the company has established itself as a critical player in the renal care ecosystem. The stock listed at a premium, reflecting positive investor sentiment towards its dominant market position and scalable service model.

Nephrocare Health Services Share Price & Listing Performance

Nephrocare Health Services shares listed on the NSE today at Rs 490, marking a premium of 6.52% over its IPO issue price of Rs 460. The listing aligns with the steady demand seen during its subscription phase and the stable Grey Market Premium (GMP) leading up to the debut.

  • Listing Date: December 17, 2025

  • IPO Issue Price: Rs 460 per share

  • Listing Price: Rs 490 per share (NSE)

  • Intraday High: Track live on the chart above.

  • Market Cap: Approx. Rs 4,900 Crore+ (based on listing price)

Note: For the latest Nephrocare Health Services share price, charts, and volume data, please refer to the live data section at the top of this page.

The Business of Nephrocare Health Services: How It Earns

Nephrocare Health Services operates under the brand NephroPlus, focusing exclusively on providing high-quality dialysis services. It has pioneered a unique "dialysis-as-a-service" model in India, partnering with hospitals to manage their dialysis units.

  • Core Business Model: The company operates on a revenue-sharing or fixed-fee model with partner hospitals. By taking over the operations, equipment, and staffing of dialysis centers, NephroPlus ensures standardised care while reducing the administrative burden on hospitals.

  • Network & Scale: It runs India’s largest network of dialysis centers, serving thousands of chronic kidney disease (CKD) patients daily. The network spans across metros, Tier-2, and Tier-3 cities, ensuring accessibility to life-saving treatments.

  • Revenue Drivers:

    • Dialysis Sessions: The primary revenue source is the fee charged per dialysis session, often covered by private insurance or government health schemes (like PMJAY).

    • Ancillary Services: Revenue is also generated from related services such as fistula procedures, catheterisations, and pharmacy sales within its centers.

    • International Presence: The company has also expanded its footprint internationally, with centers in markets like the Philippines and Uzbekistan, diversifying its revenue streams.

Major News & Developments

  • IPO Success: The Nephrocare Health Services IPO, which closed on December 12, 2025, raised a total of Rs 871.05 Crore. The issue comprised a fresh issue of Rs 353.40 Crore and an Offer for Sale (OFS) of Rs 517.64 Crore.

  • Fund Utilisation: The net proceeds from the fresh issue will be utilised for:

    • Network Expansion: Setting up new dialysis centers across India and select international markets.

    • Medical Equipment: Upgrading existing infrastructure with advanced hemodialysis machines.

    • Marketing & Branding: Increasing awareness about kidney health and the NephroPlus brand.

  • Anchor Investment: Prior to the public issue, the company successfully raised Rs 260.26 Crore from marquee anchor investors, signalling strong institutional confidence in its business fundamentals.

What You Can Find on This Company Page

This page is your comprehensive resource for tracking Nephrocare Health Services Limited.

  • Live Share Price: Real-time BSE/NSE quotes, percentage change, and volume.

  • Financials: Quarterly results, profit & loss statements, and key ratios (P/E, EBITDA margins).

  • Shareholding Pattern: Updates on promoter holdings and institutional participation post-listing.

  • Peer Comparison: Compare Nephrocare's valuation with other healthcare service providers like Apollo Hospitals and Max Healthcare.

Frequently Asked Questions (FAQs)

What is the current share price of Nephrocare Health Services?

The live share price is available at the top of this page. The stock listed on December 17, 2025, at Rs 490 on the NSE.

What does Nephrocare Health Services do?

Nephrocare Health Services, operating as NephroPlus, is a leading provider of dialysis services. It partners with hospitals to set up and manage dialysis centers, offering standardised and high-quality renal care to patients.

When did Nephrocare Health Services list?

The company’s shares were listed on the BSE and NSE on December 17, 2025.

Is NephroPlus a profitable company?

You can view the detailed financial statements and profit/loss trends in the "Financials" tab on this page to assess the company's profitability and growth trajectory

What was the issue price of the Nephrocare Health IPO?

The IPO price band was Rs 438 – Rs 460 per share, and the shares were issued at the upper band of Rs 460.

Read More
X